Help Us Expand the Use of an Innovative Treatment for Arrhythmia

The Interventional Arrhythmia Center at the American Hospital of Paris offers expertise when it comes to treating and curing heart rhythm disorders. To continue delivering world-class medical care to its patients, the Hospital must acquire a Carto® heart navigation and mapping system, a revolutionary device used to perform ablation procedures as a cure for arrhythmia.
Please help us finance this tool, which is crucial for curing heart rhythm disorders, particularly atrial fibrillation.
Funding in progress
98.3% of the project financed / Total Budget: €160,000
Rythmologie interventionnelle
iStock/BioSense

A Permanent Cure for Arrhythmia

In line with the latest international recommendations, the American Hospital of Paris aims to guarantee permanent recovery from arrhythmia by expanding the use of a major medical innovation.

 

rythmologie

Curing Arrythmia with Radiofrequency Ablation or Cryoablation

To eliminate the electrical short circuits that cause arrhythmia, medication was the preferred remedy for years, but this solution is not effective over the long term. The patient always relapses and may also suffer from serious side effects. Today, the French, European and American health authorities mainly recommend radiofrequency ablation or cryoablation as the first-line treatment, because ablation is the only option that guarantees permanent recovery from the disease.

Focus on Atrial Fibrillation

This minimally invasive procedure is performed under general anesthesia to ensure the patient is comfortable. The doctor inserts a catheter into a vein in the groin and guides it to the atria, where the pulmonary veins connect to the heart. By fusing a 3D image of the heart with an image produced by a 3D scanner, the Carto® heart navigation and mapping system produces an ultra high definition picture which is used to view heart muscle contractions and identify any short circuits. Two options are then proposed: radiofrequency ablation or cryoablation to eliminate the short circuits.

  • Heat from the radiofrequency energy creates scar tissue which isolates the abnormal electrical signals and prevents them from travelling throughout the heart.
  • With cryoablation, a tiny balloon is inflated at the opening of the pulmonary vein. The temperature of the balloon is brought down to -60° C using a special coolant gas. A catheter verifies the electrical disconnection in real time.

Regardless of the method used, ablation is the ultimate illustration of technical prowess. Today at the American Hospital of Paris, the risk of complication has been lowered to almost zero thanks to technological advances and the mastery of the technique. For the patient, this represents a chance for full recovery from the disease.

Support this Major Medical Innovation

By making a gift to the American Hospital of Paris today, you will help finance the purchase of the cardiac mapping system we need to perform radiofrequency ablations and cryoablations to treat heart arrhythmias, particularly atrial fibrillation. This major medical innovation will enhance care for all patients concerned.

Overall Investment Budget:  €160,000
Funds Already Raised: €157,400
Still Needed: €2,600

100 patients benefit per year

Thank you for your generosity!

As a recognized institution of public benefit, the American Hospital of Paris is authorized to receive donations and bequests, allowing you to benefit from tax advantages. As soon as we receive your donation, we will send you a tax receipt enabling you to claim your tax reduction.

“Arrhythmia can be a true disability and can very quickly hinder a patient’s ability to walk, for example. Atrial fibrillation accounts for 90% of all arrhythmias, increases the risk of mortality by 46% and multiplies the risk of stroke by 2.4. Ablation allows the patient to return to their normal activities, significantly improve quality of life and enjoy longer life expectancy. Being able to propose this therapeutic strategy at the American Hospital of Paris is a major advantage for patients.
I would like to thank in advance all those who choose to support this major medical innovation for our patients.

Dr. Thierry Zerah, Head of the Interventional Arrhythmia Center